Member Type: Large Biotech/Pharmaceutical Companies
Astellas Pharma Global Development is the research and development arm of Tokyo-based Astellas Pharma Inc., the second-largest Japan-based pharmaceutical company. At Astellas, our commitment to R&D is based on the development of first-in-class and best-in-class products in our therapeutic areas of focus. In the U.S., our robust pipeline is centered on the therapeutic areas of oncology, urology, cardiology, infectious disease, organ transplantation, neuroscience and dermatology. In the area of oncology, Astellas subsidiary Agensys, Inc of Santa Monica, California is developing a promising pipeline of therapeutic fully human monoclonal antibodies to treat solid tumor cancers. Astellas is proud of its commitment to changing tomorrow by discovering and developing innovative therapies that address unmet medical needs. All global development programs are run out of the Astellas headquarters for the Americas located in Deerfield, Illinois. For more information about our global research and development activities, please visit our Web site.